
CME
CME Group Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
278.380
Open
276.600
VWAP
277.14
Vol
158.18K
Mkt Cap
100.09B
Low
276.340
Amount
43.84M
EV/EBITDA(TTM)
11.38
Total Shares
360.38M
EV
101.47B
EV/OCF(TTM)
24.18
P/S(TTM)
9.25
CME Group Inc. provides a derivatives marketplace. The Company enables clients to trade futures, options, cash and over the counter (OTC) markets, optimize portfolios, and analyze data. It exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural products and metals. It offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it operates central counterparty clearing provider, CME Clearing. Its products provide a means for hedging, speculation and asset allocation related to the risks associated with, among other things, interest rate sensitive instruments, and changes in the prices of agricultural, energy and metal commodities. It provides clearing and settlement services for a range of exchange-traded futures and options on futures contracts and OTC derivatives.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q4
FY2026Q1
1.58B
-0.58%
2.708
+1.04%
1.60B
+5.08%
2.683
+6.46%
1.67B
+1.91%
2.893
+3.33%
Estimates Revision
The market is revising Downward the revenue expectations for CME Group Inc. (CME) for FY2025, with the revenue forecasts being adjusted by -0.02% over the past three months. During the same period, the stock price has changed by 0.39%.
Revenue Estimates for FY2025
Revise Downward

-0.02%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward

+0.12%
In Past 3 Month
Stock Price
Go Up

+0.39%
In Past 3 Month
13 Analyst Rating

3.62% Upside
Wall Street analysts forecast CME stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CME is 288.25 USD with a low forecast of 211.00 USD and a high forecast of 313.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
5 Hold
1 Sell
Moderate Buy

3.62% Upside
Current: 278.187

Low
211.00
Averages
288.25
High
313.00

3.62% Upside
Current: 278.187

Low
211.00
Averages
288.25
High
313.00
Barclays
Benjamin Budish
Equal Weight
downgrade
$299 -> $298
2025-07-24
Reason
Barclays
Benjamin Budish
Price Target
$299 -> $298
2025-07-24
downgrade
Equal Weight
Reason
Barclays analyst Benjamin Budish lowered the firm's price target on CME Group to $298 from $299 and keeps an Equal Weight rating on the shares. The company reported a Q2 earnings beat but is facing tough compares in Q3, the analyst tells investors in a research note.
Oppenheimer
Owen Lau
Outperform
maintain
$300 -> $303
2025-07-24
Reason
Oppenheimer
Owen Lau
Price Target
$300 -> $303
2025-07-24
maintain
Outperform
Reason
Oppenheimer analyst Owen Lau raised the firm's price target on CME Group (CME) to $303 from $300 and keeps an Outperform rating on the shares. The firm notes CME delivered again another record quarter with revenue, ADV, adjusted operating income and adjusted EPS achieving all-time highs and were up double-digits year-over-year. Revenue was better than expected due to higher RPC, and expense guidance was dialed down due to lower spend on Google (GOOGL) migration and professional services. Given the positive results, the stock was up 0.7% vs. up 0.8% for S&P 500 at close, Oppenheimer adds.
UBS
Buy -> Neutral
downgrade
$305
2025-07-24
Reason
UBS
Price Target
$305
2025-07-24
downgrade
Buy -> Neutral
Reason
UBS downgraded CME Group to Neutral from Buy with an unchanged price target of $305. The firm cites valuation for the downgrade with the shares up 19% year-to-date. Geopolitical uncertainty drove volumes and CME shares higher over the past year, but trading activity has started to slow recently, the analyst tells investors in a research note. UBS does not see increased retail trading leading to significant near-term upside for the company. It reduced estimates for CME below consensus for fiscal 2025.
Morgan Stanley
Overweight
maintain
$304 -> $303
2025-07-24
Reason
Morgan Stanley
Price Target
$304 -> $303
2025-07-24
maintain
Overweight
Reason
Morgan Stanley lowered the firm's price target on CME Group to $303 from $304 and keeps an Overweight rating on the shares. Record volumes in Q2 showcased broad based strength, says the analyst, who sees macro conditions supporting volumes growth better than expectations as customers face greater need to manage and hedge risk.
RBC Capital
Ashish Sabadra
Sector Perform
maintain
$269 -> $282
2025-07-24
Reason
RBC Capital
Ashish Sabadra
Price Target
$269 -> $282
2025-07-24
maintain
Sector Perform
Reason
RBC Capital analyst Ashish Sabadra raised the firm's price target on CME Group to $282 from $269 and keeps a Sector Perform rating on the shares. Near-term market dynamics supported solid volume growth in Q2, while Market and Data Information continues to benefit from increased subscriber growth and pricing tailwinds, the analyst tells investors in a research note.
Piper Sandler
Patrick Moley
Overweight
maintain
$283 -> $296
2025-07-15
Reason
Piper Sandler
Patrick Moley
Price Target
$283 -> $296
2025-07-15
maintain
Overweight
Reason
Piper Sandler analyst Patrick Moley raised the firm's price target on CME Group to $296 from $283 and keeps an Overweight rating on the shares. Heading into Q2 earnings, the firm expects management teams to strike a positive tone on the outlook for volumes and growing momentum in retail derivatives trading. However, the exchange businesses will face difficult year-over-year comparable sales in the second half of 2025 as they lap elevated second half of 2024 volumes impacted by the U.S. Presidential Election. With that in mind, Piper sees more upside in diversified, less volume-sensitive stocks.
See All Ratings
Valuation Metrics
The current forward P/E ratio for CME Group Inc (CME.O) is 24.71, compared to its 5-year average forward P/E of 24.68. For a more detailed relative valuation and DCF analysis to assess CME Group Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair
5Y Average PE
24.68
Current PE
24.71
Overvalued PE
28.52
Undervalued PE
20.83
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair
5Y Average EV/EBITDA
20.80
Current EV/EBITDA
21.57
Overvalued EV/EBITDA
23.36
Undervalued EV/EBITDA
18.23
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
13.77
Current PS
15.08
Overvalued PS
15.34
Undervalued PS
12.21
Financials
Annual
Quarterly
FY2025Q2
YoY :
+24.58%
3.21B
Total Revenue
FY2025Q2
YoY :
+29.47%
2.65B
Operating Profit
FY2025Q2
YoY :
+16.07%
1.03B
Net Income after Tax
FY2025Q2
YoY :
+16.12%
2.81
EPS - Diluted
FY2025Q2
YoY :
+37.09%
1.04B
Free Cash Flow
FY2025Q2
YoY :
+11.58%
37.97
FCF Margin - %
FY2025Q2
YoY :
-6.83%
31.93
Net Margin - %
FY2025Q2
YoY :
+13.93%
12.51
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
2.9M
USD
7
3-6
Months
12.5M
USD
7
6-9
Months
5.2M
USD
3
0-12
Months
3.6M
USD
7
Bought
0-3
2
72.3K
USD
Months
3-6
2
72.0K
USD
Months
6-9
4
390.1K
USD
Months
0-12
2
64.0K
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
662.7K
Volume
13
6-9
Months
770.2K
Volume
15
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
9
2.0M
Volume
Months
6-9
10
1.9M
Volume
Months
0-12
1
467.1K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
65.0K
USD
2
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
8.0K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
2
16.0K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
2.9M
USD
7
3-6
Months
12.5M
USD
7
6-9
Months
5.2M
USD
3
0-12
Months
3.6M
USD
7
Bought
0-3
2
72.3K
USD
Months
3-6
2
72.0K
USD
Months
6-9
4
390.1K
USD
Months
0-12
2
64.0K
USD
Months
CME News & Events
Events Timeline
2025-07-23 (ET)
2025-07-23
07:01:53
CME Group reports Q2 adjusted EPS $2.96, consensus $2.92

2025-07-22 (ET)
2025-07-22
15:02:07
CME Group, Nasdaq announced ten-year extension of Nasdaq-100 futures license

2025-07-10 (ET)
2025-07-10
05:10:39
CME Group reports Q2 ADV 9.2M contracts

Sign Up For More Events
Sign Up For More Events
News
7.5
07-30WSJStocks Fall After Powell Remarks on Potential Rate Cut Dim Investor Hopes
9.5
07-28NASDAQ.COMCME Group Revenue Jumps 10% in Q2
7.0
07-25WSJCME Group Wins Lawsuit by Former Floor Traders
Sign Up For More News
People Also Watch

DJT
Trump Media & Technology Group Corp
17.860
USD
+0.51%

BTI
British American Tobacco plc
53.610
USD
+0.85%

IBKR
Interactive Brokers Group Inc
66.630
USD
+0.62%

SNPS
Synopsys Inc
642.570
USD
-0.43%

CDNS
Cadence Design Systems Inc
374.860
USD
+1.03%

CTAS
Cintas Corp
224.830
USD
+0.76%

APH
Amphenol Corp
107.440
USD
+1.85%

WELL
Welltower Inc
166.150
USD
-0.14%

CI
Cigna Group
280.310
USD
-5.89%

AON
Aon PLC
358.710
USD
+0.95%
FAQ

What is CME Group Inc (CME) stock price today?
The current price of CME is 278.1869 USD — it has increased 0.16 % in the last trading day.

What is CME Group Inc (CME)'s business?

What is the price predicton of CME Stock?

What is CME Group Inc (CME)'s revenue for the last quarter?

What is CME Group Inc (CME)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for CME Group Inc (CME)'s fundamentals?

How many employees does CME Group Inc (CME). have?
